Literature DB >> 9219575

Antimutagenic effects of dehydrozingerone and its analogs on UV-induced mutagenesis in Escherichia coli.

N Motohashi1, Y Ashihara, C Yamagami, Y Saito.   

Abstract

Antimutagenic activities of dehydrozingerone, benzalacetone and its analogs substituted with the hydroxyl, methoxyl or methyl group on the benzene ring were investigated by the post-treatment for UV-induced mutagenesis in Escherichia coli WP2s (uvrA). In this assay, dehydrozingerone was a poor antimutagen. Among the test compounds except for 2-hydroxybenzalacetone, benzalacetone was the most strong antimutagen, showing that the ring substitutions decrease the antimutagenic activities. 2-Hydroxybenzalacetone was, however, more effective than benzalacetone. The antimutagenicity of 2-hydroxybenzalacetone might be dependent on the property that is known to associate inter-molecularly by hydrogen bonding between the hydroxyl group and the carbonyl group. The effects of the side chain, single, double or triple bond and its adjacent carbonyl group, were further investigated using benzylacetone with saturated carbonyl chain, benzalacetone with double-bonded carbonyl chain, 4-phenyl-3-butyn-2-one with triple-bonded carbonyl chain and trans-beta-methyl styrene with only double bond. Benzalacetone and 4-phenyl-3-butyn-2-one suppressed the UV-induced mutagenesis, but benzylacetone and trans-beta-methyl styrene scarcely inhibited the mutagenesis: an alpha, beta-double or triple-bonded carbonyl system was necessary for the antimutagenic activity. 4-Phenyl-3-butyn-2-one showed the potent antimutagenicity at one order lower concentrations than that of benzalacetone. Benzalacetone, 2-hydroxybenzalacetone and 4-phenyl-3-butyn-2-one that were effective on the UV-induced mutagenesis also decreased the gamma-induced mutagenesis in Salmonella typhimurium TA2638.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9219575     DOI: 10.1016/s0027-5107(97)00054-7

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  7 in total

1.  Antitumor agents. 258. Syntheses and evaluation of dietary antioxidant--taxoid conjugates as novel cytotoxic agents.

Authors:  Kyoko Nakagawa-Goto; Koji Yamada; Seikou Nakamura; Tzu-Hsuan Chen; Po-Cheng Chiang; Kenneth F Bastow; Shao-Chun Wang; Bill Spohn; Mien-Chie Hung; Fang-Yu Lee; Fang-Chen Lee; Kuo-Hsiung Lee
Journal:  Bioorg Med Chem Lett       Date:  2007-07-04       Impact factor: 2.823

Review 2.  Phenylpropanoids in radioregulation: double edged sword.

Authors:  Wanyeon Kim; Ki Moon Seong; BuHyun Youn
Journal:  Exp Mol Med       Date:  2011-06-30       Impact factor: 8.718

3.  Dehydrozingerone, chalcone, and isoeugenol analogues as in vitro anticancer agents.

Authors:  Jin Tatsuzaki; Kenneth F Bastow; Kyoko Nakagawa-Goto; Seiko Nakamura; Hideji Itokawa; Kuo-Hsiung Lee
Journal:  J Nat Prod       Date:  2006-10       Impact factor: 4.050

Review 4.  Natural product-based radiopharmaceuticals: Focus on curcumin and its analogs, flavonoids, and marine peptides.

Authors:  Hendris Wongso
Journal:  J Pharm Anal       Date:  2021-07-21

5.  Structure-function activity of dehydrozingerone and its derivatives as antioxidant and antimicrobial compounds.

Authors:  Ismail Rahath Kubra; Bheemanakere Kempaiah Bettadaiah; Pushpa Srinivas Murthy; Lingamallu Jagan Mohan Rao
Journal:  J Food Sci Technol       Date:  2011-08-17       Impact factor: 2.701

Review 6.  A Review on Pharmacological Properties of Zingerone (4-(4-Hydroxy-3-methoxyphenyl)-2-butanone).

Authors:  Bilal Ahmad; Muneeb U Rehman; Insha Amin; Ahmad Arif; Saiema Rasool; Showkat Ahmad Bhat; Insha Afzal; Ishraq Hussain; Sheikh Bilal; Manzoor ur Rahman Mir
Journal:  ScientificWorldJournal       Date:  2015-05-27

7.  Differential response of C57BL/6J mouse and DBA/2J mouse to optic nerve crush.

Authors:  Justin P Templeton; Mohamed Nassr; Felix Vazquez-Chona; Natalie E Freeman-Anderson; William E Orr; Robert W Williams; Eldon E Geisert
Journal:  BMC Neurosci       Date:  2009-07-30       Impact factor: 3.288

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.